Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,032 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Caring for COVID-19 patients through a pandemic in the intensive care setting: A narrative review.
Dushianthan A, Griffiths M, Hall F, Nolan K, Richardson D, Skinner B, Matthews L, Charles D, Elsheikh R, Pignatari R, Rahman R, Theivendrampillai S, Egglestone R, Stokes A, Danibenvenutti G, Stewart M, Celinski M, Cusack R, Gupta S, Saeed K. Dushianthan A, et al. Among authors: hall f. WIREs Mech Dis. 2022 Nov;14(6):e1577. doi: 10.1002/wsbm.1577. Epub 2022 Jul 14. WIREs Mech Dis. 2022. PMID: 35835688 Free PMC article. Review.
Clinical decision aids and computed tomography coronary angiography in patients with suspected acute coronary syndrome.
Wang KL, Taggart C, McDermott M, O'Brien R, Oatey K, Keating L, Storey RF, Felmeden D, Curzen N, Kardos A, Roobottom C, Smith J, Goodacre S, Newby DE, Gray AJ; RAPID-CTCA Investigators. Wang KL, et al. Emerg Med J. 2024 Jun 10:emermed-2024-213904. doi: 10.1136/emermed-2024-213904. Online ahead of print. Emerg Med J. 2024. PMID: 38857986
Developing a pragmatic consensus procedure supporting the ICH S1B(R1) weight of evidence carcinogenicity assessment.
Bassan A, Steigerwalt R, Keller D, Beilke L, Bradley PM, Bringezu F, Brock WJ, Burns-Naas LA, Chambers J, Cross K, Dorato M, Elespuru R, Fuhrer D, Hall F, Hartke J, Jahnke GD, Kluxen FM, McDuffie E, Schmidt F, Valentin JP, Woolley D, Zane D, Myatt GJ. Bassan A, et al. Among authors: hall f. Front Toxicol. 2024 Apr 5;6:1370045. doi: 10.3389/ftox.2024.1370045. eCollection 2024. Front Toxicol. 2024. PMID: 38646442 Free PMC article.
Opioid receptor antagonists reduce motivated wheel-running behavior in mice.
Kitanaka N, Arai K, Takehara K, Hall FS, Tomita K, Igarashi K, Sato T, Uhl GR, Kitanaka J. Kitanaka N, et al. Among authors: hall fs. Behav Pharmacol. 2024 Apr 1;35(2-3):114-121. doi: 10.1097/FBP.0000000000000769. Epub 2024 Feb 19. Behav Pharmacol. 2024. PMID: 38451023
A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's.
Tornling G, Edenius C, Pauling JD, Denton CP, Olsson A, Kowalski J, Murray A, Anderson M, Bhat S, Del Galdo F, Hall F, Korkosz M, Krasowska D, Olas J, Smith V, van Laar JM, Vonk MC, Wojteczek A, Herrick AL. Tornling G, et al. Among authors: hall f. Rheumatology (Oxford). 2024 Jan 30:keae049. doi: 10.1093/rheumatology/keae049. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38291895
1,032 results